GLA
AVNS

Great Lakes Advisors’s Avanos Medical AVNS Stock Holding History

Great Lakes Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-165,041
Closed -$11.3M – 564
2018
Q3 		$11.3M Sell
165,041
-12,987
-7% -$836K 0.25% 89
2018
Q2 		$10.2M Sell
178,028
-1,969
-1% -$104K 0.24% 98
2018
Q1 		$8.29M Buy
179,997
+51,119
+40% +$2.43M 0.2% 115
2017
Q4 		$5.95M Buy
128,878
+16,827
+15% +$773K 0.13% 145
2017
Q3 		$5.05M Buy
112,051
+6,621
+6% +$283K 0.12% 154
2017
Q2 		$4.14M Buy
105,430
+18,128
+21% +$685K 0.1% 182
2017
Q1 		$3.33M Buy
87,302
+14,735
+20% +$574K 0.09% 203
2016
Q4 		$2.68M Buy
72,567
+322
+0.4% +$11.5K 0.07% 219
2016
Q3 		$2.5M Sell
72,245
-17,893
-20% -$627K 0.07% 227
2016
Q2 		$2.93M Sell
90,138
-206
-0.2% -$6.31K 0.08% 223
2016
Q1 		$2.6M Buy
+90,344
New +$2.41M 0.07% 235

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Great Lakes Advisors's AVNS Position: Q4 2018 in Review

Great Lakes Advisors sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 165,041 shares — an estimated $11.3M sold.

Great Lakes Advisors first reported a position in AVNS in Q1 2016 and held it in 11 quarters. The position peaked at $11.3M in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Great Lakes Advisors reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Great Lakes Advisors sold 165,041 Avanos Medical shares in Q4 2018, an estimated $11.3M.
  • Great Lakes Advisors first reported a position in Avanos Medical in Q1 2016 and held it in 11 quarters.
  • Great Lakes Advisors's Avanos Medical position peaked at $11.3M in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Great Lakes Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.